REDEFINING SUCCESS
DEAD

Serial Number

77039012

Owner

Angiotech Pharmaceuticals, Inc.

Attorney

Kevin S. Costanza

Filing Date

Nov 7, 2006

Add to watchlist:

No watchlists yet
View on USPTO

REDEFINING SUCCESS Trademark

Serial Number: 77039012

REDEFINING SUCCESS is a trademark filed by Angiotech Pharmaceuticals, Inc. on November 7, 2006. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Angiotech Pharmaceuticals, Inc. (86 trademarks)

1618 Station Street
Vancouver V6A1B6 , CA

Entity Type: 03

Trademark Details

Filing Date

November 7, 2006

Registration Date

Not Registered

Published for Opposition

April 15, 2008

Goods & Services

cardiovascular grafts; vascular grafts; surgical dressings, namely, vascular dressings; bandages for vascular dressings; biological implants, namely, processed human or animal connective tissue in the nature of collagen implants; medical adhesive tape, namely, umbilical tape; wound dressings, namely, non-invasive topical hemostasis pads; and bronchial dilators; wound fasteners, namely, adhesive gels

medical stents; ophthalmic implants comprised of artificial material; orthopedic implants comprised of artificial material; otolaryngology implants comprised of artificial material; plastic surgery implants comprised of artificial material; genitourinary implants comprised of artificial material; gastrointestinal implants comprised of artificial material; dural implants comprised of artificial material; neurological implants comprised of artificial material; anastomosis devices, namely, medical shunts and neurological shunts; cardiovascular catheters; gastrointestinal catheters; genitourinary catheters; adhesive bands for medical purposes, namely, surgical adhesions barriers; medical devices for use in administering fluids and drugs, namely, cardiovascular infusion lines and cardiovascular ports; angioplasty balloons; implants made of artificial material for use in treatment of the neurological system, namely, dural patches; medical ultrasound apparatus, namely, medical devices with echogenic surfaces produced by coatings that enhance ultrasound imaging and ultrasound imaging in procedures; medical ultrasound apparatus, namely, medical devices with echogenic surfaces produced by mechanical roughening of the surfaces that enhance diagnostic ultrasound imaging and ultrasound imaging medical procedures; medical device for controlling bleeding, namely, hemostatic flow valves; biopsy instruments; punctual occlusion products for medical use, namely, medical introducers and punctal plugs; cannulae; predilators, namely, medical introducers; medical introducers in the nature of coaxial dilators; stents; medical guidewires; catheters; blood vessel catheters; coronary angio-plastic catheters; catheters for interventional radiology; catheter sets consisting primarily of catheters; balloon catheters; central venous catheters; infusion catheters; medical apparatus for placing surgical instruments, namely, retrieval baskets; introducer systems consisting of catheters, medical guidewires, medical syringes and needles for medical use; vascular ports; medical tubing in the nature of peripherally inserted central catheter lines; trans-lumbar sets consisting of catheters, medical guidewires, medical syringes and needles for medical use; connectors for connecting surgical and medical tubing; drainage appliances for surgical procedures, namely, drainage bags for use in radiology, gastroenterology, urology and gynecology; surgical knives, namely, knives used to create incisions for cataract or refractive surgery; surgical and ophthalmic blades, knives and scalpels; surgical blades, namely, scalpel blades; scalpel and medical knife handles; surgical ligature string; sutures; suture materials, namely, dressing forceps, forceps for medical use; needles for medical use, namely, suture needles; needled sutures; medical and surgical needles; surgical staples; surgical clips; surgical knives; protectors and guards for medical needles and other medical sharps; replaceable elements for suture attaching equipment; foreign body retrieval apparatus for medical use, namely, forceps; anastomosis devices, namely, shunts; cloth cushion covers for rigid eye protectors for post surgery eye protection; artificial limbs, eyes and teeth; orthopedic articles and implants, namely, orthopedic joint implants, orthopedic belts, orthopedic braces, orthopedic supports, splints; surgical instruments, namely, trocars and punctures; bone setting machines and instruments, namely, bone drills, and fixation pins; drainage appliances for surgical procedures, namely, drainage tubes and bags; screw dilators, namely, bougies; patient monitoring sensors and apparatus, namely, invasive monitoring equipment in the nature of electrodes and transdermal ports; medical instruments for use in performing biopsies; needles for medical use, namely, biopsy needles; biopsy instruments, namely, biopsy sample guns; biopsy instruments, namely, bone marrow biopsy devices; biopsy instruments, namely, reusable handle biopsy guns; biopsy instruments, namely, adjustable automated aspiration device for use in medical biopsies; surgical and medical apparatus and instruments for use in general surgery, namely, punctum plugs; bone cement delivery instruments for medical use; knives for medical use, namely, cystotomes; hypodermic syringes; hypodermic needles; surgical apparatus and instruments for use in ophthalmic surgery, namely, tumor-excising surgical instrument, cortex extractors, iris retractors, lens loops, and capsulotomy kits and syringes; intravenous sets comprised primarily of intravenous feeding bottles and intravenous feeding tubes; breast biopsy site markers for use in medical procedures; implants made of artificial material in the nature of surgical meshes for medical use, and meshes having drug eluting and bioresorbing functions for use in treating the unwanted growth of tissues at surgical sites; and all of the aforementioned goods having lubricious polymer coatings

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Feb 9, 2009 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 9, 2009 ABN6
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jul 8, 2008 NOAM
PUBLISHED FOR OPPOSITION
Apr 15, 2008 PUBO
NOTICE OF PUBLICATION
Mar 26, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 12, 2008 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 10, 2008 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 10, 2008 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 10, 2008 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 10, 2008 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 10, 2008 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Mar 10, 2008 ZZZX
WITHDRAWN FROM PUB - EXAMINING ATTORNEY REQUEST
Mar 10, 2008 PBER
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 9, 2008 PREV
ASSIGNED TO LIE
Mar 9, 2008 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 14, 2008 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 14, 2008 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 14, 2008 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 14, 2008 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 14, 2008 CNEA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 6, 2008 ERFR
EX PARTE APPEAL-INSTITUTED
Feb 6, 2008 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Feb 6, 2008 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Feb 6, 2008 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 7, 2007 GNFN
FINAL REFUSAL E-MAILED
Aug 7, 2007 GNFR
FINAL REFUSAL WRITTEN
Aug 7, 2007 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 17, 2007 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 17, 2007 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 17, 2007 TROA
NON-FINAL ACTION E-MAILED
Jan 30, 2007 GNRT
NON-FINAL ACTION WRITTEN
Jan 30, 2007 CNRT
ASSIGNED TO EXAMINER
Jan 29, 2007 DOCK
NEW APPLICATION ENTERED
Nov 13, 2006 NWAP